Clinical Trial Update: Impact of Splenectomy on the Efficacy of Targeted Therapy and Immunotherapy in Unresectable HCC Patients With Cirrhotic Portal Hypertension

View source ↗

Summary

This clinical trial update notes a study evaluating whether splenectomy influences the effectiveness of targeted therapy and immunotherapy in patients with hepa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: Zhiyong Huang | Conditions: Unresectable Hepatocellular Carcinoma | Status: RECRUITING